Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 277Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 14Cymbalta

PharmaCompass

01

Brand Name : Cymbalta

Duloxetine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Cymbalta

arrow
Medlab Asia & Asia Health
Not Confirmed

Duloxetine

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 239

2018 Revenue in Millions : 222

Growth (%) : 8

blank

02

Brand Name : Cymbalta

Duloxetine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Cymbalta

arrow
Medlab Asia & Asia Health
Not Confirmed

Duloxetine

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 768

2019 Revenue in Millions : 725

Growth (%) : 6

blank

03

Brand Name : Cymbalta

Duloxetine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Cymbalta

arrow
Medlab Asia & Asia Health
Not Confirmed

Duloxetine

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 251

2019 Revenue in Millions : 244

Growth (%) : 3

blank

04

Brand Name : Cymbalta

Duloxetine

arrow
Medlab Asia & Asia Health
Not Confirmed

05

Brand Name : Cymbalta

Duloxetine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Cymbalta

arrow
Medlab Asia & Asia Health
Not Confirmed

Duloxetine

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 171

2020 Revenue in Millions : 241

Growth (%) : -24

blank

06

Brand Name : Cymbalta

Duloxetine

arrow
Medlab Asia & Asia Health
Not Confirmed

07

Brand Name : Cymbalta

Duloxetine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Cymbalta

arrow
Medlab Asia & Asia Health
Not Confirmed

Duloxetine

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 48

2021 Revenue in Millions : 170

Growth (%) : -72

blank

08

Brand Name : Cymbalta

Duloxetine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Cymbalta

arrow
Medlab Asia & Asia Health
Not Confirmed

Duloxetine

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 28

2022 Revenue in Millions : 48

Growth (%) : -34

blank

09

Brand Name : Cymbalta

Duloxetine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Cymbalta

arrow
Medlab Asia & Asia Health
Not Confirmed

Duloxetine

Main Therapeutic Indication : Neuroscience and Mental Health

Currency : USD

2015 Revenue in Millions : 1,615

2014 Revenue in Millions : 1,028

Growth (%) : -36%

blank

10

Brand Name : Cymbalta

Duloxetine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Cymbalta

arrow
Medlab Asia & Asia Health
Not Confirmed

Duloxetine

Main Therapeutic Indication : Neuroscience/Mental Health

Currency : USD

2014 Revenue in Millions : -68.20%

2013 Revenue in Millions :

Growth (%) :

blank